IBEX Innovations Limited (IBEX) was founded by Dr Gary Gibson in 2010 and really took off in 2011, after investment to develop and commercialise an innovative X‑ray detector technology capable of generating high sensitivity materials information from standard X-ray detectors. In January 2017, IBEX was awarded ISO9001:2008 and ISO13485:2012 accreditation by auditors LRQA.
The IBEX technology has developed rapidly from an initial concept to fully engineered solutions, and the company is now seeing increasing commercial adoption in security, food inspection and medical markets.
IBEX employs a team of highly-skilled and dedicated scientists, engineers and business professionals at its modern facilities on NETPark, Sedgefield, UK. Details of the Board of Directors can be found here.
The company is working with the Mathematics Department at Durham University on development of the core technology and maintains close links with both the Newcastle‑upon‑Tyne Hospitals NHS Trust and the South Tees NHS Trust to validate medical imaging applications of the IBEX technology.
The development of IBEX is being supported by venture‑capital funding from Northstar Ventures, IP Group and Nordson Incorporated; more information about them can be found here. IBEX is also grateful for financial support through grants from InnovateUK and the European Commission. Patent information can be found here.